Cargando…
18 F-FDG-PET/MRI in patients with Graves’ orbitopathy.
PURPOSE: Currently, therapeutic management of patients with Graves’ orbitopathy (GO) relies on clinical assessments and MRI. However, monitoring of inflammation remains difficult since external inflammatory signs do not necessarily represent the orbital disease activity. Therefore, we aimed to evalu...
Autores principales: | Weber, Manuel, Deuschl, Cornelius, Bechrakis, Nikolaos, Umutlu, Lale, Antoch, Gerald, Eckstein, Anja, Binse, Ina, Oeverhaus, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478760/ https://www.ncbi.nlm.nih.gov/pubmed/34406498 http://dx.doi.org/10.1007/s00417-021-05339-1 |
Ejemplares similares
-
Planning health care for patients with Graves’ orbitopathy
por: Sasim, Inna V., et al.
Publicado: (2008) -
Relative selenium insufficiency is a risk factor for developing severe Graves’ orbitopathy: a case–control study
por: Lumyongsatien, Mingkwan, et al.
Publicado: (2021) -
Balancing orbital volume reduction and redistribution for a tailored surgical treatment in Graves’ ophthalmopathy
por: Costan, Victor Vlad, et al.
Publicado: (2020) -
Monocanalicular versus bicanalicular intubation in the treatment of congenital nasolacrimal duct obstruction
por: Komínek, Pavel, et al.
Publicado: (2011) -
Success rate and complications of endonasal dacryocystorhinostomy with unciformectomy
por: Yang, Jae Wook, et al.
Publicado: (2012)